Patent details

EP2585104 Title: METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

Basic Information

Publication number:
EP2585104
PCT Application Number:
US2011041926
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP117990374
PCT Publication Number:
WO2011163650
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
French Title of Invention:
PROCÉDÉS ET COMPOSITIONS POUR L'ADMINISTRATION AU SNC D'ARYLSULFATASE A
German Title of Invention:
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR ABGABE DER ARYLSULFATASE A IN DAS ZNS
SPC Number:

Dates

Filing date:
25/06/2011
Grant date:
21/08/2019
EP Publication Date:
01/05/2013
PCT Publication Date:
29/12/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/08/2019
EP B1 Publication Date:
21/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/06/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/10/2024
 
 

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, 540-8645, Osaka , Japan (JP)

History of Owners

From:
14/08/2019
To:
09/10/2024

Name:
Shire Human Genetic Therapies, Inc.
Address:
300 Shire Way, Lexington MA 02421, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
04/09/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CALIAS, Pericles
Address:
United States (US)

2

Name:
CAMPOLIETO, Paul
Address:
United States (US)

3

Name:
SHAHROKH, Zahra
Address:
United States (US)

4

Name:
SALAMAT-MILLER, Nazila
Address:
United States (US)

5

Name:
TAYLOR, Katherine
Address:
United States (US)

6

Name:
CHARNAS, Lawrence
Address:
United States (US)

7

Name:
PAN, Jing
Address:
United States (US)

8

Name:
WRIGHT, Teresa Leah
Address:
United States (US)

Priority

1

Priority Number:
358857 P
Priority Date:
25/06/2010
Priority Country:
United States (US)

2

Priority Number:
360786 P
Priority Date:
01/07/2010
Priority Country:
United States (US)

3

Priority Number:
387862 P
Priority Date:
29/09/2010
Priority Country:
United States (US)

4

Priority Number:
201161435710 P
Priority Date:
24/01/2011
Priority Country:
United States (US)

5

Priority Number:
201161442115 P
Priority Date:
11/02/2011
Priority Country:
United States (US)

6

Priority Number:
201161476210 P
Priority Date:
15/04/2011
Priority Country:
United States (US)

7

Priority Number:
201161495268 P
Priority Date:
09/06/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/19; A61K 38/46; A61K 38/47; A61P 25/00; A61P 25/28;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201934
Publication date:
21/08/2019
Description:
Grant (B1)

2

Issue number:
201939
Publication date:
25/09/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20240000416A
Date Registered:
09/10/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, 540-8645, Osaka , Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/05/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
04/09/2019 Power Of Attorney 1
18/09/2019 Outgoing Correspondence 1
09/10/2024 Request For Change 45
09/10/2024 Outgoing Correspondence 1